Clinical Research

The intention of the study is to demonstrate superiority of Saruparib (AZD5305) + physician's choice NHA relative to placebo + physician's choice NHA by assessment of radiographic progression-free survival (rPFS) in participants with mCSPC.

I Want to Participate

Wondering if you qualify as a candidate for this trial? Visit the "View Trial" button below and print the trial's details to discuss with your Cancer Care Northwest physician. 

View Trial

For More Information
If you are interested in this clinical trial,please email the Cancer Care Northwest Research Department at research@ccnw.net for more information. Be sure to include:

• Your name
• Phone number & if we can leave a voice message at this number
• Trial number(s) you are interested in
• Name and city of clinic you are currently being treated